Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
LY ›
LYPLYZE
Trademark search for:
LYPLYZE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-11-05 — Application filed
2019-11-08 — Application filed
2019-11-12 — Application filed
2020-02-10 — Assigned to examiner
2020-02-17 — Approved for pub - principal register
2020-03-04 — Notification of notice of publication e-mailed
2020-03-24 — Published for opposition
2020-03-24 — Official gazette publication confirmation e-mailed
2020-05-19 — Noa e-mailed - sou required from applicant
2020-10-01 — Attorney/dom.rep.revoked and/or appointed
2020-10-01 — Teas change of owner address received
2020-10-01 — Teas change of correspondence received
2020-10-01 — Applicant/correspondence changes (non-responsive) entered
2020-10-01 — Teas revoke/app/change addr of atty/dom rep received
2020-11-18 — Sou teas extension received
2020-11-18 — Sou extension 1 filed
2020-11-18 — Sou extension 1 granted
2020-11-20 — Notice of approval of extension request e-mailed
2021-05-16 — Sou teas extension received
2021-05-16 — Sou extension 2 filed
2021-05-16 — Sou extension 2 granted
2021-05-18 — Notice of approval of extension request e-mailed
2021-11-16 — Sou teas extension received
2021-11-16 — Sou extension 3 filed
2021-11-16 — Sou extension 3 granted
2021-11-18 — Notice of approval of extension request e-mailed
2021-12-01 — Automatic update of assignment of ownership
2022-05-10 — Sou teas extension received
2022-05-10 — Sou extension 4 granted
2022-05-10 — Sou extension 4 filed
2022-05-12 — Notice of approval of extension request e-mailed
2022-07-05 — Assigned to examiner
2022-11-20 — Sou teas extension received
2022-11-20 — Sou extension 5 filed
2022-12-01 — Case assigned to intent to use paralegal
2022-12-05 — Sou extension 5 granted
2022-12-06 — Notice of approval of extension request e-mailed
2023-06-19 — Application abandoned
2023-06-19 — Final status recorded
2023-06-20 — Application abandoned
Owner Information
NOVARTIS AG
The Medicines Company
The Medicines Company
Correspondent
Maury M. Tepper, III Tepper & Eyster, PLLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
